FDA Wants to Shut Down Adult Stem Cell Therapy as its Healing Successes are Experienced Around the World
Adult stem cell therapy is enjoying widespread success around the world, but if the FDA gets its way, it may soon be banned here in the U.S. There have been nearly 12,000 adult stem cell therapies performed in the United States with an over 90 percent success healing rate for mostly joint and spinal conditions. It involves using the patient's own stem cells, so no patent-able drugs are involved. They are targeting the most influential stem cell clinician in the U.S., Dr. Kristin Comella in Florida. The FDA has allegedly offered to drop their lawsuit if Dr. Comella signs an agreement to stop doing adult stem cell therapy and no longer promote it. She refused. She said she has witnessed people leave their wheelchairs for good from this therapy. The trial is set for a Federal Court hearing beginning June 2019, in Miami, Florida. If Dr. Comella loses this court case, adult stem cell therapy in the USA may be forced out of the country and only be available to those who can afford medical tourism.